Minoxidil in androgenic alopecia: New formulations with Improved delivery

Alaa Al-taie; Myasar M. Al-kotaji; Hani M. Almukhtar

Volume 18, Issue 2 , December 2021, , Page 53-63

https://doi.org/10.33899/iphr.2022.170397

Abstract
  Background: Minoxidil was introduced into the market as a hypotensive agent, however, aftermarketing, the hypertrichosis side effect was reported by almost all users. This adverse effect encourages the repositioning or repurposing the use of minoxidil as a topical preparation for the treatment of hair ...  Read More ...